MedPath

Study for regulating reactive T cells against allograft and tumor

Not Applicable
Conditions
Organ transplantation Malignant tumor
Registration Number
JPRN-UMIN000039682
Lead Sponsor
Hiroshima University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
50
Inclusion Criteria

Not provided

Exclusion Criteria

1, The person with regular hospital visit 2, THe person who have a axiuos about thier health. 3, The person with weight less than 40kg. 4, the person who did blood donation within 1 month. 5, The person possibly be pregnant. 6, The person has a history of infectious disease within a week. 7, The person who has a direct interst with the investigators, like teacher and student. 8, The person who is recognized as inappropriate for the candidate by investigators.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Frequency of antigen specific T cell in allo and tumor specific stimulation
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath